LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)

Clinical trial NCT03725605 · COMPLETED

Trial details

NCT number: NCT03725605
Sponsor: Lytix Biopharma AS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma

Start date: 2018-12-28
Primary completion: 2021-07-02
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.